HPLC-MS Determination of Risperidone and 9-Hydroxy-risperidone in Plasma and Its Application in Clinical Pharmacokinetics Study

SU Fen-li,ZHOU Zhi-ling,LI Huan-de

2006-01-01

Abstract:Objective:To establish an HPLC-MS method for the determination of risperidone(RIP) and its metab- olite 9-hydroxy-risperidone (9-OH-RIP) in plasma and to study their pharmacokinetics in Chinese female schizophrenia patients.Methods:Twenty-four Chinese female schizophrenia patients were given multiply dose ris- peridone tablets.The plasma samples were collected at predetermined time points.0.5 mL of each plasma sample was alkalized with 0.1 mL of 0.1 mol·L~(-1)sodium hydroxide solution and extracted with 5.0 mL ethyl ether.The plasma concentrations of risperidone and 9-hydroxy-risperidone were determined by HPLC-MS method using MACHEREY-NAGEL C_(18)analytical column (4.6mm×250mm,5μm),acetonitrile-30 mmol·L~(-1) ammonium acetate and 1.7 mmol·L~(-1) formic acid (85:15) as mobile phase,with positive ion SIM detection of risperidone ([MH]~+,m/z=411)and 9-hydroxy-risperidone([MH]~+,m/z=427) using quetiapine ([MH]~+,m/z=384) as internal standard.Results:The calibration curves were linear within the concentration range of 0.5-200μg· L~(-1) of risperidone and 5-250μg·L~(-1) in plasma(r=0.9905 and 0.9926).The limit of quantitation was 0.5μg ·L~(-1) for both analytes(S/N=9).The extraction recovery was78.4% and the method recovery was90%.The relative standard deviations for the intra-day and inter-day were14.2% for both analytes.The plasma concen- trations risperidone and 9-hydroxy-risperidone were as follows:t_(max) was (1.7±0.99),(2.3±0.74) h,respec- tively;t_(1/2)was (3.1±1.4),(25.3±8.1)h,respectively;C_(max)~(ss)was (84.8±54.5),(145.7±41.1 μg·L~(-1),re- spectively;C_(min)~(ss) was (13.6±17.5),(79.5±23.7μg·L~(-1),respectively;C_(av)~(ss)was (30.5±26.5),(136.8±37.2 μg·L~(-1),respectively;C_(0→12)~(ss) was (451.8±404.3μg·h·L~(-1)for risperidone and C_(0→48)~(ss) was(3986.2±1175.8μg ·h·L~(-1)for 9-hydroxy-risperidone;C_(0→∞)~(ss)was(482.1±418.8),(5511.6±1975.5μg·h·L~(-1),respectively; K_e was(1.6±0.9),(2.6±0.8) h~(-1),respectively;CL/F and V/F of risperidone were (88.9±62.1)L·h~(-1) and (361.4±282.3)L,respectively.Conclusions:The assay method is simple,fast and efficient and usable for its clinical pharmacokinetics study.